Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

The Assistance Fund Announces Partnership With JCPenney
Healthcare & PharmaceuticalPartnerships

The Assistance Fund Announces Partnership With JCPenney

June 23, 2026 12:00 PM

The Assistance Fund (TAF), an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced a national partnership with JCPenney that will provide members of the TAF community with exclusive savings on apparel, home goods, accessories, and more.Through the partnership, patients receive an exclusive online and in-store coupon that provides a deep discount and...

Read more
NX Development Corp. Celebrates One-Year Anniversary of Gleolan(R) Commercial Control With Record-Breaking Sales
Healthcare & PharmaceuticalCompany Update

NX Development Corp. Celebrates One-Year Anniversary of Gleolan(R) Commercial Control With Record-Breaking Sales

June 23, 2026 11:00 AM

NX Development Corp. recently celebrated the one-year anniversary of Gleolan's return to our commercial control and we would like to take this opportunity to thank our loyal customers for their continued support.We are proud to report that Gleolan has achieved record-breaking unit sales along with significant growth in our customer base over the past year, both of which are a testament to the clinical value of Gleolan and the trust our customers...

Read more
Bio-Based Solvents Take Center Stage at CHEMUK
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Bio-Based Solvents Take Center Stage at CHEMUK

June 23, 2026 11:00 AM

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, took center stage at CHEMUK 2026 with the launch of its first bio-based solvent portfolio for HPLC and LCMS, underscoring how sustainability is reshaping both science and business. These solvents-including ethanol, methanol and acetonitrile-are designed to reduce reliance on fossil-based materials and lower environmental footprints, all without...

Read more
Apta Health Helps Employers Expose Hidden Fees and Inefficiencies in Medical and Rx Spending as Healthcare Costs Continue to Rise
Healthcare & PharmaceuticalProduct Announcements

Apta Health Helps Employers Expose Hidden Fees and Inefficiencies in Medical and Rx Spending as Healthcare Costs Continue to Rise

June 23, 2026 10:00 AM

After two years of building and refining its market check technology, Apta Health is bringing new visibility to its Medical and Rx Market Checks through Apta Connect.Apta Connect is Apta Health's proprietary software platform that reviews a group's medical and pharmacy claims, compares them to industry data sets, and shows where the plan may be overpaying or missing lower cost opportunities.Many employers have historically treated their health...

Read more
Revecore Launches ReClaim(TM), an AI-Native Platform Built for the Complexity Modern Hospitals Face
Healthcare & PharmaceuticalProduct Announcements

Revecore Launches ReClaim(TM), an AI-Native Platform Built for the Complexity Modern Hospitals Face

June 23, 2026 9:03 AM

Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced the launch of Revecore ReClaim™, an AI-powered revenue recovery intelligence platform and the technology foundation behind every Revecore service. ReClaim builds on the AI-driven underpayment recovery and clinical appeals capabilities announced in April. The platform extends that investment into a unified, AI-native...

Read more
Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Healthcare & PharmaceuticalCompany Update

Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

June 23, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that the company has completed submission of its New Animal Drug Application (NADA) to the U.S. Food and Drug Administration's Center for Veterinary Medicine for full approval of crofelemer for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Crofelemer, under the name Canalevia®-CA1, is currently conditionally approved for this indication in dogs."We're very happy to have...

Read more
AGS Health Expands Leadership Team, Deepening Its Commitment to RCM AI Innovation and Strategic Growth
Healthcare & PharmaceuticalManagement Changes

AGS Health Expands Leadership Team, Deepening Its Commitment to RCM AI Innovation and Strategic Growth

June 23, 2026 9:00 AM

In a reflection of its accelerating investment in AI, automation, data management, and company growth, AGS Health® today announced the expansion of its executive leadership team. These appointments underscore the company's commitment to delivering on the promise of revenue cycle AI through practical innovation, clinical expertise, and ROI-driven solutions. As a provider of tech-enabled revenue cycle management (RCM) solutions and a strategic...

Read more
CVS Health: Thank You! Mews at St. Mary Grand Opening - Williamstown, NJ
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Health: Thank You! Mews at St. Mary Grand Opening - Williamstown, NJ

June 23, 2026 9:00 AM

Last week, we proudly celebrated the Grand Opening and Building Dedication of Mews at St. Mary in Williamstown, NJ, alongside our amazing colleagues, local leaders, community organizations, development partners, and The Bishop of Camden. Mews at St. Mary is now home to 75 affordable homes for seniors, thoughtfully designed to encourage community, friendship, and support for our aging population. Developed by The Diocese of Camden and The Walters...

Read more
TRNR CEO to Participate in Fireside Chat at Maxim Group's Health, Wellness & Longevity Conference on July 22, 2026
Healthcare & PharmaceuticalCompany Update

TRNR CEO to Participate in Fireside Chat at Maxim Group's Health, Wellness & Longevity Conference on July 22, 2026

June 23, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today announced that Co-Founder and Chief Executive Officer Trent Ward has been invited to participate in a fireside chat at Maxim Group's Health, Wellness & Longevity Conference on Wednesday, July 22, 2026.The session will be a one-on-one discussion moderated by Thomas Forte,...

Read more
Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities
Healthcare & PharmaceuticalCompany Update

Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities

June 23, 2026 8:30 AM

Stemtech Corporation (OTCID:STEK), a The Pioneer and global leader in stem cell nutrition and plant-based wellness solutions, today issued a joint letter to shareholders from Chairman and Chief Executive Officer Charles S. Arnold and President and Chief Operating Officer John W. Meyer, outlining the Company's strategic progress in 2025 and the initiatives positioning the Company for growth in 2026 and beyond.To Our Shareholders:2025 was a year...

Read more
Renowned Life Science Leader Dr. Gino Martini Joins KIFFIK Biomedical as Chief Scientific Officer
Healthcare & PharmaceuticalManagement Changes

Renowned Life Science Leader Dr. Gino Martini Joins KIFFIK Biomedical as Chief Scientific Officer

June 23, 2026 8:00 AM

KIFFIK Biomedical today announced that Luigi (Gino) Martini, Ph.D., FRPharmS, MBA, has been appointed Chief Scientific Officer (CSO).Dr. Martini's career spans senior leadership roles across global pharmaceutical companies including GSK, Roche, Shire, and Catalent, as well as academic appointments at King's College London and policy leadership at the Royal Pharmaceutical Society. His work has focused on oncology, rare diseases, precision...

Read more
LEM Surgical Announces second FDA 510(k) Clearance for Next-Generation Humanoid Robotic Surgical System
Healthcare & PharmaceuticalCompany Update

LEM Surgical Announces second FDA 510(k) Clearance for Next-Generation Humanoid Robotic Surgical System

June 23, 2026 7:00 AM

LEM Surgical Inc., a pioneer in advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted an additional 510(k) clearance for its Dynamis Robotic Surgical System. This landmark milestone introduces further capabilities to the groundbreaking, surgical humanoid architecture that is focused on the global orthopedic and spine surgery market.The Dynamis Robotic Surgical System...

Read more
Who Does the Best Mini Lift in Florida?
Healthcare & PharmaceuticalAdvertorial

Who Does the Best Mini Lift in Florida?

June 23, 2026 6:00 AM

As demand grows for facial rejuvenation procedures with shorter recovery times and natural-looking outcomes, many patients are searching for surgeons who specialize in mini facelift techniques rather than traditional full facelift surgery. In Florida, where cosmetic facial procedures remain among the most requested aesthetic surgeries, patients increasingly compare surgeons based on training, procedural innovation, surgical volume, and long-term...

Read more
Who Is Really Influencing Trump Marijuana Rescheduling?
Healthcare & PharmaceuticalCompany Update

Who Is Really Influencing Trump Marijuana Rescheduling?

June 23, 2026 1:25 AM

On June 29, the Drug Enforcement Administration (DEA) will convene what may become the most consequential marijuana hearing in modern American history.The hearing is intended to help build the administrative record supporting-or opposing-the proposed transfer of marijuana from Schedule I to Schedule III under the Controlled Substances Act. That record is supposed to be built on evidence.Chemistry. Manufacturing controls. Pharmacology....

Read more
SoCalBio Unveils New Brand Reflecting Greater LA's Growth as a Global Bioscience Hub
Healthcare & PharmaceuticalCompany Update

SoCalBio Unveils New Brand Reflecting Greater LA's Growth as a Global Bioscience Hub

June 22, 2026 6:30 PM

SoCalBio, the leading trade association representing the life sciences, medical technology and biopharmaceutical community in Greater Los Angeles, today unveiled a new brand identity at the BIO International Convention. Created by SoCalBio member RKS Design, the rebrand reflects both the transformation of the region's bioscience ecosystem and SoCalBio's growing role in uniting innovators, entrepreneurs, and researchers with industry leaders and...

Read more
ZetrOZ Systems Introduces sam 3.0 Multi-hour Continuous Ultrasound Wearable Technology, The Next Evolution in Recovery
Healthcare & PharmaceuticalProduct Announcements

ZetrOZ Systems Introduces sam 3.0 Multi-hour Continuous Ultrasound Wearable Technology, The Next Evolution in Recovery

June 22, 2026 1:20 PM

ZetrOZ Systems, the inventor of sustained acoustic medicine, today announces the launch of sam® 3.0, the latest evolution of its revolutionary wearable ultrasound device that has been clinically validated in more than 30 studies as accelerating healing and recovery from soft-tissue injuries. Built on the technological foundation of the sam® 2.0 device, the new device provides significant enhancements in battery performance, charging speed, user...

Read more
Marijuana Rescheduling DEA Judge Violates the Constitution? DEA Is Holding a ALJ Hearing Next Week
Healthcare & PharmaceuticalCompany Update

Marijuana Rescheduling DEA Judge Violates the Constitution? DEA Is Holding a ALJ Hearing Next Week

June 22, 2026 11:50 AM

MMJ International Holdings, together with its subsidiaries MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc. (collectively, "MMJ"), is asking a simple question ahead of the Drug Enforcement Administration's June 29 marijuana rescheduling hearing:If the Department of Justice has already acknowledged a constitutional defect in the Administrative Law Judge system, why is DEA proceeding as though the problem does not exist? The question...

Read more
Vanna Health Raises $17 Million to Expand Evidence-Based Care for People Living with Serious Mental Illness
Healthcare & PharmaceuticalFinancing

Vanna Health Raises $17 Million to Expand Evidence-Based Care for People Living with Serious Mental Illness

June 22, 2026 10:00 AM

Vanna Health, a value-based health technology company that provides integrated mental and chronic health support through community-based coaching, today announced the close of a $17 million funding round. The round was co-led by a national insurer and AlleyCorp, with participation from Health Velocity Capital. The funding will support the expansion of Vanna Health's clinical reach, deepen its technology infrastructure, and bring its...

Read more
Pharmacist and IT Researcher Ramchandra Pudasaini Explores AI-Driven Medication Management and Healthcare Data Integration
Healthcare & PharmaceuticalAdvertorial

Pharmacist and IT Researcher Ramchandra Pudasaini Explores AI-Driven Medication Management and Healthcare Data Integration

June 22, 2026 10:00 AM

From Pharmacy to Artificial Intelligence: How Ramchandra Pudasaini Is Exploring Technology-Driven Solutions for Medication Management and Healthcare Innovation Healthcare systems worldwide continue to face challenges related to medication errors, fragmented healthcare data, disconnected clinical workflows, and increasing demands for data-driven decision-making. While digital transformation continues to reshape healthcare delivery, the challenge...

Read more
NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Healthcare & PharmaceuticalCompany Update

NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo

June 22, 2026 9:30 AM

NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company") today announced that it has shipped the NV-387 Oral Gummies Drug Product for a Phase II Clinical Trial of Monkeypox Treatment to the Democratic Republic of Congo (DRC), in preparation for enrollment of patients.Clinical Trial Site preparations are being performed by our CRO in India, Om Sai Clinical Research Pvt. Ltd., and associates in DRC. The CRO personnel have visited the site several...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?